Feb 24, 2026Joint Health and Cartilage Support: What the Evidence ShowsCartilage has limited self-repair capacity, but several interventions modestly slow degradation and reduce symptoms. Here is what the clinical evidence supports for joint health in aging.
Feb 20, 2026Gout and Uric Acid: Evidence-Based Management Beyond MedicationGout is driven by uric acid crystal deposition, but diet, supplements, and lifestyle all modulate uric acid levels. Here is what the evidence shows.
Feb 20, 2026Osteoarthritis Symptom Load: Boswellia, Curcumin, and Ginger Trial EvidenceAdjunctive supplement evidence in osteoarthritis is strongest for modest pain and function support, with outcomes depending on extract quality, dose, and adherence.
Feb 19, 2026Glucosamine for Joints: Cartilage Evidence, Cardiovascular Signal, and Sulfate vs HydrochlorideGlucosamine sulfate has modest RCT evidence for slowing cartilage loss and reducing joint pain in knee osteoarthritis. An unexpected but consistent epidemiological signal links glucosamine use with lower cardiovascular mortality — the mechanism may involve AMPK activation.
Feb 16, 2026Collagen Peptides: Joint Pain, Skin Aging, Bone Density, and Bioavailability EvidenceHydrolyzed collagen peptides are absorbed as dipeptides and tripeptides that accumulate in cartilage, skin, and bone tissue. RCTs show meaningful joint pain reduction in osteoarthritis and sports-related joint discomfort. Skin hydration and elasticity benefits are well-replicated. Evidence for bone density is emerging.
Jan 30, 2026Osteoarthritis and Supplements: Curcumin, Boswellia, Glucosamine — Evidence vs PlaceboOsteoarthritis supplement evidence is mixed. Curcumin and boswellia show consistent anti-inflammatory benefit. Glucosamine evidence is ambiguous — some trials show structural benefit, others don't. This article maps what evidence supports at realistic doses.